Lymphocyte-mediated regulation of β-endorphin in the myenteric plexus
Journal Articles
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
Lymphocytes are antinociceptive and can modulate visceral pain perception in mice. Previously, we have shown that adoptive transfer of CD4+ T cells to severe combined immune-deficient (SCID) mice normalized immunodeficiency-related visceral hyperalgesia. Pain attenuation was associated with an increase in β-endorphin release by T cells and an upregulation of β-endorphin in the enteric nervous system. In this study, we investigated the relationship between T cells and opioid expression in the myenteric plexus. We examined opioid peptide and receptor expression in the myenteric plexus in the presence and absence of mucosal T cells. We found a positive association between T cells and β-endorphin expression; this was accompanied by a downregulation of the μ-opioid receptor (MOR). In vitro, T helper (Th) type 1 and type 2 cytokine stimulation of CD4+ T cells or isolation of T cells from in vivo Th-polarized mice did not increase T cell release of β-endorphin or the induction of β-endorphin expression in the myenteric plexus. However, exogenous β-endorphin did upregulate β-endorphin expression, and both cycloheximide and naloxone methiodide inhibited peptide upregulation. Therefore, our results suggest that nonpolarized CD4+ T cells release β-endorphin, which, through an interaction with MOR, stimulates an upregulation of β-endorphin expression in the myenteric plexus. Thus, we propose that the mechanism underlying lymphocyte modulation of visceral pain involves T cell modulation of opioid expression in the enteric nervous system.
